Yongtian Zhao

Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study

Kaichao Feng, Yang Liu, Yongtian Zhao et al. · Journal for ImmunoTherapy of Cancer · 2020 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

Case Report: Low-Dose Decitabine Plus Anti-PD-1 Inhibitor Camrelizumab for Previously Treated Advanced Metastatic Non-Small Cell Lung Cancer

Xin Yan, Yongtian Zhao, Yang Liu et al. · Frontiers in Oncology · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer

Fen Feng, Huake Sun, Zhikun Zhao et al. · Journal of Oncology · 2022 · 17 citations · Full text

Medicine, Genetics, Oncology +17

Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series

Chengjing Zhou, Ting Jiang, Yajie Xiao et al. · Frontiers in Immunology · 2021 · 15 citations · Full text

Medicine, Immunology, Oncology +17

A prospective, phase II, single-arm study of neoadjuvant/conversion therapy with camrelizumab, apatinib, S-1 ± oxaliplatin for locally advanced cT4a/bN+ gastric cancer.

Li Song, Wenbin Yu, Fei Xie et al. · Journal of Clinical Oncology · 2021 · 12 citations

Medicine, Oncology, Pharmacology +17